Can an aspirin a day keep liver cancer away?

Prof Dr,DRAM,HIV /AIDS,HEPATITIS ,SEX DISEASES & WEAKNESS expert,New Delhi,India, +917838059592

A new study presented this week at The Liver Meeting-- held by the American Association for the Study of Liver Diseases -- found that daily aspirin therapy was significantly associated with a reduced risk in hepatitis B virus‐related liver cancer.

        Hepatitis B is a viral infection that attacks the liver. HBV can be contracted through contact with an infected person's blood or other bodily fluid, and the infection can either be acute or chronic. According to AASLD's Guidelines for Treatment of Chronic Hepatitis B, an estimated 240 million people worldwide have chronic HBV, and the highest prevalence of the virus is in Africa and Asia. Death from HBV is commonly due to the development of cirrhosis (scaring of healthy liver tissue) or hepatocellular carcinoma (liver cancer).Past research suggests that daily aspirin therapy -- which is often prescribed to prevent cardiovascular disease -- may also prevent the development of cancer. However, clinical evidence is lacking for the effectiveness of aspirin therapy in preventing HBV‐related liver cancer so a large cohort study conducted by Researchers at Taichung Veterans General Hospital in Taichung, Taiwan.

                     They concluded that Cumulative incidence of liver cancer in the group treated with aspirin therapy was significantly lower than that in the untreated group in five years. In their multivariate regression analysis, the researchers found aspirin therapy was independently associated with reduced liver cancer risk. Sensitivity subgroup analyses also verified this association. Older age, male gender, cirrhosis and diabetes also were independently associated with an increased risk, but nucleos(t)ide analogue or statin use was associated with a decreased risk.

              So use of Aspirin being recommended to prevent cancer in Hepatitis B patient as in colorectal carcinoma .